Learn More
The aim of this study was to investigate the therapeutic efficacy of α-radioimmunotherapy of ovarian cancer in mice using different fractionated treatment regimens. The study was performed using the monoclonal antibody MX35 F(ab) 2 labeled with the α-particle emitter 211 At. Methods. Nude mice were intraperitoneally inoculated with ∼1 × 10 7 cells of the(More)
  • 1